Corroborating our observation of CCL2′s association with tumor progression, the limited reports on MCPs in CRC have indicated, albeit not unanimously [52], an increase in CCL2 expression along with an advancing clinical stage, which has been accompanied by the accumulation of TAMs [53,54]. Here, CCL2 is linked to colorectal carcinoma.